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ABSTRACT
Introduction: Even in developed economies infectious
diseases remain the most common cause of illness in
early childhood. Our current understanding of the
epidemiology of these infections is limited by
reliance on data from decades ago performed using
low-sensitivity laboratory methods, and recent studies
reporting severe, hospital-managed disease.
Methods and analysis: The Observational Research
in Childhood Infectious Diseases (ORChID) study is an
ongoing study enrolling a dynamic birth cohort to
document the community-based epidemiology of viral
respiratory and gastrointestinal infections in early
childhood. Women are recruited antenatally, and their
healthy newborn is followed for the first 2 years of life.
Parents keep a daily symptom diary for the study child,
collect a weekly anterior nose swab and dirty nappy
swab and complete a burden diary when a child meets
pre-defined illness criteria. Specimens will be tested for
a wide range of viruses by real-time PCR assays.
Primary analyses involves calculating incidence rates
for acute respiratory illness (ARI) and acute
gastroenteritis (AGE) for the cohort by age and
seasonality. Control material from children when they
are without symptoms will allow us to determine what
proportion of ARIs and AGE can be attributed to
specific pathogens. Secondary analyses will assess the
incidence and shedding duration of specific respiratory
and gastrointestinal pathogens.
Ethics and dissemination: This study is approved
by The Human Research Ethics Committees of the
Children’s Health Queensland Hospital and Health
Service, the Royal Brisbane and Women’s Hospital and
The University of Queensland.
Trial registration: clinicaltrials.gov NCT01304914.
INTRODUCTION
Even in developed economies where popula-
tions have high-quality housing, sanitation,
secure food and drinking water supplies,
good personal hygiene standards, widespread
vaccine use and access to high-quality medical
care, infectious diseases remain the most
ARTICLE SUMMARY
Article focus
▪ Infectious diseases are a common cause of
morbidity in early childhood, even in developed
economies.
▪ A diagnostic gap exists for common respiratory
and gastrointestinal syndromes, with the likeli-
hood that as yet undiscovered pathogens are
involved.
▪ Existing knowledge about these common ill-
nesses relies on research conducted before the
rapid developments in molecular diagnostics of
recent decades or focuses on disease at the
severe end of the spectrum—hospitalisations—
affecting a limited number of children and dis-
counting the burden of more common, but less
severe, community-managed illness.
Key messages
▪ This protocol outlines a dynamic birth cohort
study that will allow for a detailed description of
the epidemiology of respiratory and gastrointes-
tinal viruses during the first 2 years of life.
▪ The large biobank of specimens to be collated
will act as a rich source of material to answer
targeted research questions, including the role of
virus acquisition and shedding on clinical illness
and the discovery of new infectious agents.
Strengths and limitations of this study
▪ As study procedures, including specimen collec-
tion and return, are conducted by parents, find-
ings will be free from Hawthorne effects due to
frequent interactions with study staff.
▪ Systematic weekly sampling will provide a
control set of specimens for the individual and
the cohort, allowing quantification of virus-
specific attributable risk to illness.
▪ Non-random recruitment and enrolment requires
awareness and assessment of potential bias and
confounding prior to broad-based generalisation.
▪ Similar studies in the past have oversampled
from higher socioeconomic households, and we
attempt to avoid this by using a recruitment
strategy that targets pregnant women in both
public and private hospital settings.
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common cause of signiﬁcant morbidity, and occasionally
mortality, in early childhood.1–6 Our current understand-
ing of the epidemiology of early childhood infections is
limited by reliance on community-based data from
decades ago using low-sensitivity diagnostic methods,7–9
and recent studies that primarily focus on severe,
hospital-managed disease.10 11 Much of what we know,
especially with newly discovered agents, originates from
hospital-based prevalence studies where more than 80%
of cases are less than 2 years of age, representing the
sickest 2–3% of young children seen. Experience with
inﬂuenza illustrates how easily disease burden can be
underestimated by extrapolating from hospital data.12–14
Available community-based studies also have important
methodological limitations, such as sampling from highly
selected subject populations, lack of adequate control
subjects, restricted sampling frequency and observation
periods, small subject numbers and/or reporting on only
a few or single agents.13 15–18 A key methodological issue
is the use of home visits by healthcare workers or the
requirement for clinic visits for specimen collection.
Both are likely to be an imposition on busy families,
regardless of the setting, leading to biased estimates of
infection events and specimen availability.19
The highest incidence rates of acute respiratory infec-
tions (ARI) are during the ﬁrst 2 years of life where on
average infants experience six to eight ARIs each year.20
Complication rates from acute otitis media (30%) and
sinusitis (8%) are also highest in this age group,21 while
3–5% of all infants are hospitalised for viral lower respira-
tory tract infections, including bronchiolitis, pneumonia,
croup and secondary bacterial pneumonia.22 There is
emerging evidence that infectious insults to the growing
and developing lung during early childhood contribute
to the pathogenesis of chronic pulmonary disorders in
older children and adulthood, such as asthma,23 chronic
obstructive pulmonary disease24 25 and bronchiectasis.26
Young children are often household introducers, actively
transmitting respiratory infections to other family
members.27 Taken together, ARIs in children result in
enormous current and future costs to the healthcare
system, families and society.14
Likewise, acute gastroenteritis (AGE) is still a major
cause of childhood morbidity in high-income countries.
An average of 3.2 diarrhoeal episodes per child per year
has been reported globally, reaching as much as 12 epi-
sodes per child per year in some settings.1 Viruses remain
important causes of gastroenteritis in children from
developed countries, even after rotavirus vaccines have
been introduced. In addition to rotaviruses, noroviruses,
enteric adenoviruses and astroviruses are also important
enteric pathogens.28 Nevertheless, a large diagnostic gap
exists in developed countries where community-based
studies of at least 1 year duration report no identiﬁable
pathogen in approximately 40–60% of young children
with AGE.29–31 In contrast, recent work employing sensi-
tive molecular techniques describes two healthy infants
shedding a diverse range of enteric viruses almost
continuously throughout the ﬁrst 12–14 months of life.32
In order to ﬁrst understand and then prevent early-
childhood AGE such contradictory ﬁndings need to be
resolved.
As well as pathogens traditionally associated with child-
hood infections, there are several recently identiﬁed
respiratory and gastrointestinal agents, mostly viruses,
which may have an important role in the epidemiology
of these illnesses. Furthermore, there are likely to be
undiscovered pathogens that contribute to the remain-
ing diagnostic gap for ARI33 and AGE episodes.34
We have designed this study—Observational Research
in Childhood Infectious Diseases (ORChID)—to over-
come identiﬁed methodological issues and collect data
on the population-based epidemiology of respiratory and
gastrointestinal infections during the ﬁrst 2 years of life.
METHODS AND ANALYSIS
Study design
ORChID is a 5-year prospective, community-based, longitu-
dinal, dynamic birth cohort study of ARI and AGE epi-
sodes and respiratory and gastrointestinal pathogen
detection in children during the ﬁrst 2 years of life (clini-
caltrials.gov: NCT01304914). Recruitment will take place
over a 2-year period, the last recruited child will be fol-
lowed until their second birthday, and the ﬁnal year of the
study will be used to complete data entry and analysis,
laboratory testing of specimens and to report study ﬁnd-
ings. The progressive 2-year recruitment plan allows for
seasonal and year-to-year variation in pathogen activity.13 20
The study is designed to allow families to be self-
sufﬁcient and avoid unnecessary contact with study
staff, so as to minimise bias due to a Hawthorne effect.
Parents are interviewed every 3 months to record
immunisation status and changes in breast feeding and
childcare attendance.
An initial visit is undertaken once a child is delivered,
preferably while the mother and child are still in hos-
pital. At this visit, consent for participation is conﬁrmed,
an initial anterior nose swab and nappy swab are col-
lected from the study child, and parents are taught the
process for collecting these specimens, nasal swabs are
collected from parents, diaries and study paperwork are
reviewed and arrangements are made to retrieve cord
blood, if available.
The Human Research Ethics Committees of the
Children’s Health Queensland Hospital and Health
Service, the Royal Brisbane and Women’s Hospital and
The University of Queensland approved the study.
Study sample
Pregnant women are approached for enrolment of their
newborn infants at antenatal clinics in two hospitals:
one public (Royal Women’s Hospital, Brisbane) and
one private (Northwest Private Hospital, Everton Park).
These hospitals serve communities in northern metro-
politan Brisbane, a city of more than two million people,
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and every year each has approximately 6100 and
1700 deliveries, respectively. Exclusion criteria for enrol-
ment and ongoing participation include gestational
age at birth of less than 36 weeks, major congenital
abnormalities, chronic heart, respiratory (excluding
asthma), gastrointestinal, neurological or immunological
disorders, parents unable to converse in English, living
outside the Brisbane metropolitan region or planning to
move from the area within the next 2 years. As a
dynamic cohort study, children can leave and rejoin the
cohort as required.13
Outcomes to be measured
Following the initial visit, the study family performs the
following tasks: (1) completion of the daily symptom
diary, (2) weekly collection and return by mail to the
research laboratory of separate anterior nose and nappy
swabs and (3) when the study child has an illness that
meets speciﬁed criteria, complete an impact diary.
The daily symptom diary consists of a day-by-day tick
box framework, and has been modiﬁed from an ARI
daily diary used in previous studies to include diarrhoea
for capturing episodes of AGE.13 35 For an ARI, one or
more category A features (fever, wheezing, shortness of
breath, pulmonary congestion or moist cough or medic-
ally diagnosed otitis media and/or pneumonia) or at
least two category B features (runny nose or nasal
congestion, sore throat, cough, muscle aches, chills,
headache, irritability, decreased activity or lethargy or
weakness, or any vomiting) trigger impact diary comple-
tion. For AGE, parents record daily number of vomits
and number of loose stools. Diarrhoea, deﬁned as
three or more loose stools on a given day, will trigger
impact diary completion. These data will allow for a
gastroenteritis severity score (modiﬁed Vesikari score)
validated for ambulatory settings,36 to be calculated. The
impact diary collects information on healthcare visits,
including hospitalisations, diagnostic investigations, use
of antibiotics, missed childcare and parental time away
from work or usual activities.13 35
Parents collect an anterior nose swab and nappy swab
from the study child once a week using a plastic-shaft,
rayon budded swab, which comes with a transport tube
with a foam pad reservoir soaked with viral transport
medium (Virocult MW950, Medical Wire & Equipment,
Wiltshire, England). For the nose specimen, a single
swab is used to sample each nostril. Both specimens are
sent to the research laboratory by surface mail37 38
where they are stored in a −80° freezer.
Nose and nappy specimens are batch tested for viruses
using previously validated and reported real-time PCR
assays, or PCR assays developed speciﬁcally for this study
(table 1). Reverse transcription precedes PCR for RNA
viruses. Specimens are spiked with a known concentra-
tion of Equine Herpes Virus before extraction to assess
extraction efﬁciency and for the presence of PCR inhibi-
tors. The quality of respiratory and stool specimen col-
lection are assessed by evaluating for the presence of a
marker of human genomic DNA, ERV3.37 Appropriate
positive and negative controls are included in every run.
When more than one pathogen is detected simultan-
eously in respiratory and stool specimens, we perform a
semiquantitative analysis of individual viral nucleic acids
based on the cycle threshold (Ct) value.55 56 To further
differentiate between human rhinovirus (HRV) types a
nested PCR-based typing system encompassing partial
Table 1 Specimen type, pathogens and assay details, ORChID study, Brisbane, Queensland, Australia
Nose swab Nappy swab
Organism References Organism References
Rhinoviruses Lu et al39 Rhinoviruses
Coronaviruses
As for respiratory viruses
Arden et al40
HRSV-A and HRSV-B Lambert et al41 Bocavirus
Influenza A and influenza B
Adenoviruses Enteroviruses Maunula et al42
Parainfluenza viruses I, II, III Saffold viruses Wang et al43
HMPV Rotaviruses Freeman et al44
Jothikumar et al45
Pang et al46
Bocavirus Tozer et al47 Noroviruses Kageyama et al48
hPyV-WU O’Grady et al37 Adenoviruses To be developed for this study
hPyV-KI Bialasiewicz et al49 Saporovirus
Coronavirus OC43 Gunson et al50 Astroviruses
Coronavirus 229E Parechoviruses
Coronavirus NL63 Cosavirus
Coronavirus HKU1 Dare et al51 Klassevirus
Bordetella pertussis Probert et al52
Mycoplasma pneumonia Loens et al53
Chlamydiales species Hirama et al54
HRSV, human respiratory syncytial virus; HMPV, human metapneumovirus; hPyV, human polyomavirus.
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sequence of the 50 untranslated region (50UTR) is being
used. It accurately groups existing and newly identiﬁed
HRV and human enterovirus strains into clades, which
reﬂect current species assignments. Sequencing the
540 bp internal amplicon provides a rapid method to
assign new sequences to a genotype.57 58
Nasal and nappy samples from children during illness
periods where a known agent cannot be identiﬁed will
be used for further investigations for the presence of
as-yet-unidentiﬁed organisms. Pathogen-negative speci-
mens will be prioritised on the basis of disease severity
(hospital admission, fever). The methods employed for
new pathogen detection will include pan-viral DNA
microarrays59 and ‘next generation’ high-throughput
sequencing.60 61
The endpoints of the ﬁrst phase of this study are (1)
documentation of clinical and epidemiological data
from children with a variety of syndromic illnesses
which, along with exhaustive diagnostic testing using
sensitive molecular methods, will allow for detailed iden-
tiﬁcation and characterisation of pathogen–disease asso-
ciations, (2) establishing a well-characterised collection
of stored specimens with pathogen-testing results, which
will be invaluable for new virus discovery and (3) deter-
mining the pathogenesis of newly identiﬁed agents from
the human respiratory and gastrointestinal tracts and
better deﬁning the role of known pathogens, such as
HRVs, detected in asymptomatic children.
Sample size and data analysis plan
As respiratory syncytial virus (RSV) is the most widely
recognised respiratory agent associated with severe
disease in this age group, we chose it to use for sample
size calculations. To calculate the proportion of patho-
gens detected that are RSV to within ±2.5%, we assumed
the current proportion to be approximately 12.5%, that
conservatively each participant will have an average
of eight episodes of ARI over the course of the
study,13 20 62 the intraclass correlation coefﬁcient within
individuals is 0.07 (calculated from Lambert et al13) and
that 90% of subjects will remain enrolled at study com-
pletion (previous large cohort studies conducted by the
investigators had retention rates of 97–98%).13 63
Consequently, with α=0.05 and power of 80%, we were
required to enrol 138 infants. Similarly, if each subject
returns 80% of their weekly nasal swabs,13 we will be
able to estimate the proportion of all swabs positive for
RSV to within ±0.5%.
Primary analyses will concern the calculation of inci-
dence rates for ARI and AGE in study children for the
cohort as a whole, and by age and seasonality. The col-
lection of control material from children when they
are without symptoms will allow us to determine what
proportion of ARIs and AGE can be attributed to the
presence of speciﬁc pathogens. Secondary analyses
will assess the incidence and shedding duration of
respiratory and gastrointestinal pathogens. Analyses will
be conducted with mixed effects models with random
intercepts and slope (time effect) for each participant.
This method controls for the non-independence in out-
comes from the same participant at different times and
allows for heterogeneity between participants.
DISCUSSION
Infections are responsible for a signiﬁcant burden
during the early childhood years. We have presented
here the study protocol and data analysis plans for an
ambitious observational study: ORChID. The study has
been designed to overcome identiﬁed weaknesses in pre-
vious research, and to use modern molecular techniques
to identify infecting agents. The real value of this study
is in the establishment of a biobank of thousands of
respiratory and gastrointestinal specimens linked with
daily clinical data. As well as the testing we outline here,
we will in future be able to use the biobank for rapid
and detailed assessments of the clinical signiﬁcance
of newly identiﬁed pathogens using highly sensitive
molecular testing.
Strengths of the study include that it is community-
based and uses parent-collected specimens returned
to the diagnostic laboratory by surface mail for highly
sensitive and speciﬁc real-time PCR testing for a compre-
hensive range of viruses. Systematic weekly sampling pro-
vides a control set of specimens, from both the same
study child and all study children, during asymptomatic
periods that can act as a control for specimens collected
during periods of illness. This will allow us to quantify
the attributable risk of pathogen detection to illness.
It would not be logistically or economically possible to
conduct a study on this scale without using parent-
collected specimens that are returned to the laboratory
by surface mail. We and others have demonstrated that
collection of respiratory specimens by non-healthcare
workers is feasible19 41 64–69 and, when combined with
sensitive molecular diagnostics, does not result in any
overall signiﬁcant reduction in sensitivity for virus detec-
tion.19 41 65 68 In a small randomised controlled trial,
parent collection was no worse than a home visit by a
healthcare worker for both having a specimen collected
during an illness and having a virus identiﬁed when spe-
cimens were tested; the trend for both measures was
improved collection and identiﬁcation with parent col-
lection.19 Further, the swabs we are using have been
shown to be similarly sensitive for the detection of inﬂu-
enza nucleic acid when compared with ﬂocked swabs
combined with a universal transport media.70 We have
found that return of specimens using surface mail did
not result in reduced sensitivity when compared to
immediate and maintained freezing of specimens, even
over long distances.37 Mailing specimens has also been
shown to be an efﬁcient means of community-based
research in other settings.66 67
There remain diagnostic gaps in the identiﬁcation of
the causative agent in ARI and AGE.33 34 We have been
involved in the discovery and fuller description of newly
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identiﬁed pathogens from the human respiratory and
gastrointestinal tract.40 47 49 60 71–86 The ORChID study
will allow us to link specimens negative for known patho-
gens with symptoms and illness impact data, enabling us
to prioritise specimens for new pathogen discovery. As
well as the real possibility of discovering new agents, the
epidemiology of known viruses, including their interac-
tions,87 will be analysed.
Like most observational studies, recruitment is non-
random, requiring assessment of potential biases and
confounders prior to considering the internal and exter-
nal validity of any ﬁndings. Where reported, oversam-
pling of families from higher socioeconomic households
appears common in research similar to this study,14 63 88
although differences in incidence and cost of illnesses
mean that any impact on burden assessment is likely to
be minimal and biased towards the null. We have
attempted to avoid this selection bias by using a large,
public hospital as one of our two recruitment sites. The
role household socioeconomic status plays on incidence
and disease burden will be assessed in the study analysis.
Recruitment for the study started on 12 August 2010
with the ﬁrst study baby born on 15 September 2010.
Recruitment will continue for the 2 years planned and
is expected to conclude in December 2012. To date
(31 August 2012), there have been 163 pregnant women
recruited and 148 children enrolled. We are currently
receiving over 350 nasal and nappy swabs a month, for a
total return of more than 6000 of each specimen type.
Batch testing of the nasal swabs for respiratory viruses
has started with 5200 nasal swabs tested for 17 respira-
tory viruses to date, with laboratory staff blind to
symptom presence in study subjects.
CONCLUSION
The ORChID study is well underway having started
recruitment of pregnant women and their newborns for
2 years of intensive respiratory and gastrointestinal speci-
men collection linked with daily clinical data in 2010.
Over 12 000 specimens have been returned from
148 enrolled infants, with blinded real-time PCR started
for respiratory viruses. The study will provide unique
insights on the acquisition of viruses, duration of shed-
ding and the relationship of these to symptomatic
illness. As well as this, specimens will be available for tar-
geted discovery of new pathogens, and will provide a
rich source of material to deﬁne the epidemiology of
new agents when described by others.
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